🔎 Trials Near Me

Beranda › Leukemia Limfositik Kronis › Florida › Miami

Uji klinis Leukemia Limfositik Kronis di Miami, FL

9 studi untuk Leukemia Limfositik Kronis mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Menerima pesertaFase 3
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07321652

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Menerima pesertaFase 1/2
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05006716

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Menerima pesertaFase 3
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277231

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Menerima pesertaFase 3
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06973187

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Menerima pesertaFase 1
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05131022

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Menerima pesertaFase 2
  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT06588478

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Menerima pesertaFase 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT07218510

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Menerima pesertaFase 4
  • Sylvester Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT06876662

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Menerima pesertaFase 4
  • Sylvester Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT06876649

Uji klinis Leukemia Limfositik Kronis di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.